FADD and breast carcinoma: In this study, we first reported that FADD expression was remarkably higher in breast cancer and applied LC-MS/MS detection plus bioinformatics analysis to reveal that Rheb-mTORC1 pathway was dysregulated in breast cancer cells because of FADD knockdown.